AnticoagEvaluator
AnticoagEvaluator Summary
AnticoagEvaluator is a mobile Android app in Medical by American College of Cardiology Foundation. Released in Dec 2015 (10 years ago). It has about 30.3K+ installs and 68 ratings with a 4.80★ (excellent) average. Based on AppGoblin estimates, it reaches roughly 263 monthly active users . Store metadata: updated Nov 21, 2024.
Recent activity: 17 installs this week (48 over 4 weeks) showing below average growth View trends →
Store info: Last updated on Google Play on Nov 21, 2024 .
4.8★
Ratings: 68
Screenshots
App Description
Make informed anti thrombotic therapy decisions for AF patients.
Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com